Article Text

Download PDFPDF

How should we measure informed choice? The case of cancer screening
Free
  1. R G Jepson1,
  2. J Hewison2,
  3. A G H Thompson3,
  4. D Weller1
  1. 1Division of Community Health Sciences-General Practice, University of Edinburgh, Edinburgh, UK
  2. 2Academic Unit of Psychiatry and Behavioural Sciences, School of Medicine, University of Leeds, Leeds, UK
  3. 3School of Social and Political Studies, The University of Edinburgh, Adam Ferguson Building, Edinburgh, UK
  1. Correspondence to:
 Ms R Jepson
 Division of Community Health Sciences-General Practice, University of Edinburgh, 20 West Richmond Street, Edinburgh EH8 9DX, UK; ruth.jepsoned.ac.uk

Abstract

Informed choice is increasingly recognised as important in supporting patient autonomy and ensuring that people are neither deceived nor coerced. In cancer screening the emphasis has shifted away from just promoting the benefits of screening to providing comprehensive information to enable people to make an informed choice. Cancer screening programmes in the UK now have policies in place which state that it is their responsibility to ensure that individuals are making an individual informed choice. There is a need to evaluate whether such policies mean that those people invited for screening are making informed choices, and how comprehensive information affects other variables such as uptake, cost effectiveness, and satisfaction. At the present time, there is no validated measure of informed choice in cancer screening. Such a measure could be used to evaluate the effectiveness of interventions to increase informed choice and levels of informed choice in a population invited for screening. It could encourage health professionals to be accountable. Factors important when measuring informed choice in cancer screening include an individual’s understanding of the limitations of screening, the ability to make an autonomous choice, and the difference between choice and behaviour.

  • GMC, General Medical Council
  • NSC, National Screening Committee
  • informed choice
  • cancer screening

Statistics from Altmetric.com

Footnotes

  • Sources of support: Chief Scientist Office, Scotland

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Other content recommended for you